<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2017.00534</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Bovine WC1<sup>&#x0002B;</sup> and WC1<sup>neg</sup> &#x003B3;&#x003B4; T Lymphocytes Influence Monocyte Differentiation and Monocyte-Derived Dendritic Cell Maturation during <italic>In Vitro Mycobacterium avium</italic> Subspecies <italic>paratuberculosis</italic> Infection</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Baquero</surname> <given-names>Monica M.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x0002A;</xref>
<uri xlink:href="http://frontiersin.org/people/u/419340"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Plattner</surname> <given-names>Brandon L.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://frontiersin.org/people/u/433069"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Pathobiology, Ontario Veterinary College, University of Guelph</institution>, <addr-line>Guelph, ON</addr-line>, <country>Canada</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Geanncarlo Lugo-Villarino, UMR5089 Institut de Pharmacologie et de Biologie Structurale (IPBS), France</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Paul M. Coussens, Michigan State University, USA; Jayne Hope, University of Edinburgh, UK</p></fn>
<corresp content-type="corresp" id="cor1">&#x0002A;Correspondence: Monica M. Baquero, <email>mbaquero&#x00040;uoguelph.ca</email></corresp>
<fn fn-type="other" id="fn001"><p>Specialty section: This article was submitted to Microbial Immunology, a section of the journal Frontiers in Immunology</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>22</day>
<month>05</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>8</volume>
<elocation-id>534</elocation-id>
<history>
<date date-type="received">
<day>09</day>
<month>03</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>21</day>
<month>04</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2017 Baquero and Plattner.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Baquero and Plattner</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<p>During early <italic>Mycobacterium avium</italic> subspecies <italic>paratuberculosis</italic> (<italic>Map</italic>) infection, complex interactions occur between the bacteria, cells from the mononuclear phagocyte system (MPS) including both resident (macrophages and dendritic cells) and recruited (monocytes) cells, and other mucosal sentinel cells such as &#x003B3;&#x003B4; T lymphocytes. Though the details of early host&#x02013;pathogen interactions in cattle remain largely underexplored, our hypothesis is that these significantly influence development of host immunity and ultimate success or failure of the host to respond to <italic>Map</italic> infection. The aims of the present study were to first characterize monocyte-derived MPS cells from young calves with respect to their immunophenotype and function. Then, we set out to investigate the effects of WC1<sup>&#x0002B;</sup> and WC1<sup>neg</sup> &#x003B3;&#x003B4; T lymphocytes on (1) the differentiation of autologous monocytes and (2) the maturation of autologous monocyte-derived dendritic cells (MDDCs). To achieve this, peripheral blood WC1<sup>&#x0002B;</sup> or WC1<sup>neg</sup> &#x003B3;&#x003B4; T lymphocytes were cocultured with either autologous freshly isolated peripheral blood-derived monocytes or autologous immature MDDCs (iMDDCs). We began by measuring several markers of interest on MPS cells. Useful markers to distinguish monocyte-derived macrophages (MDMs) from MDDCs include CD11b, CD163, and CD172a, which are expressed significantly higher on MDMs compared with MDDCs. Function, but not phenotype, was influenced by WC1<sup>neg</sup> &#x003B3;&#x003B4; T lymphocytes: viability of <italic>Map</italic> harvested from monocytes differentiated in the presence of WC1<sup>neg</sup> &#x003B3;&#x003B4; T lymphocytes (dMonWC1<sup>neg</sup>) was significantly lower compared to MDMs and MDDCs. With respect to DC maturation, we first showed that mature MDDCs (mMDDCs) have significantly higher expression of CD11c, CD80, and CD86 compared with iMDDCs, and the phagocytic capacity of mMDDCs is significantly reduced compared to iMDDCs. We then showed that &#x003B3;&#x003B4; T lymphocyte subsets induce functional (reduced phagocytosis) but not phenotypic (surface marker expression) iMDDC maturation. These data collectively show that &#x003B3;&#x003B4; T lymphocytes influence differentiation, maturation, and ultimately the function of monocytes during <italic>Map</italic> infection, which has significant implications on survival of <italic>Map</italic> and success of host defense during early <italic>Map</italic> infection.</p>
</abstract>
<kwd-group>
<kwd><italic>Mycobacterium avium</italic> subspecies <italic>paratuberculosis</italic></kwd>
<kwd>&#x003B3;&#x003B4; T lymphocytes</kwd>
<kwd>WC1</kwd>
<kwd>macrophages</kwd>
<kwd>monocytes</kwd>
<kwd>dendritic cells</kwd>
<kwd>mononuclear phagocyte system</kwd>
</kwd-group>
<counts>
<fig-count count="8"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="52"/>
<page-count count="11"/>
<word-count count="7546"/>
</counts>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="introduction">
<title>Introduction</title>
<p>The mononuclear phagocyte system (MPS) comprises monocytes, macrophages, dendritic cells (DCs), and their precursors in the bone marrow (<xref ref-type="bibr" rid="B1">1</xref>). Myeloid progenitor cells give rise to circulating monocytes which migrate into various tissues where they function as resident tissue macrophages or DCs (<xref ref-type="bibr" rid="B2">2</xref>&#x02013;<xref ref-type="bibr" rid="B4">4</xref>). A primary function of cells from the MPS under normal physiologic conditions is to maintain homeostasis in peripheral tissues (<xref ref-type="bibr" rid="B5">5</xref>). During inflammatory processes, they play a crucial role initiating and regulating immune responses by processing and presenting antigens to na&#x000EF;ve T lymphocytes (<xref ref-type="bibr" rid="B6">6</xref>). Cells from the MPS share several surface markers and functions, making it difficult to clearly define the distinction between them (<xref ref-type="bibr" rid="B6">6</xref>). The phenotype of monocytes, macrophages, and DCs of humans and mice has been extensively studied and these cells have been classified according to the expression of specific markers [reviewed in Ref. (<xref ref-type="bibr" rid="B7">7</xref>)]. Classification of bovine DCs, including monocyte-derived dendritic cells (MDDCs) based on phenotype and function has been described [reviewed in Ref. (<xref ref-type="bibr" rid="B8">8</xref>)]; however, little is known about the phenotype and function of bovine monocytes, macrophages, and the expression of phenotypic surface markers after monocyte <italic>in vitro</italic> differentiation.</p>
<p>During initial exposure to pathogens at mucosal surfaces, cells from the MPS including tissue-resident macrophages and DCs interact with other immune cells, such as &#x003B3;&#x003B4; T lymphocytes at mucosal surfaces. &#x003B3;&#x003B4; T lymphocytes are considered to be a bridge between innate and adaptive immune systems. In cattle, &#x003B3;&#x003B4; T lymphocytes are classified broadly as WC1<sup>&#x0002B;</sup> and WC1<sup>neg</sup> according to their expression of the workshop cluster 1 (WC1) molecule, which is a transmembrane glycoprotein belonging to the scavenger receptor cysteine-rich family (CD163) (<xref ref-type="bibr" rid="B9">9</xref>). WC1<sup>&#x0002B;</sup> &#x003B3;&#x003B4; T lymphocytes are considered pro-inflammatory (<xref ref-type="bibr" rid="B9">9</xref>) and less is known about the function of WC1<sup>neg</sup> &#x003B3;&#x003B4; T lymphocytes; however, it is believed that they are mucosal sentinel cells, given their presence at mucosal surfaces (<xref ref-type="bibr" rid="B10">10</xref>). Human and murine &#x003B3;&#x003B4; T lymphocytes have been the most widely studied. In these species, &#x003B3;&#x003B4; T lymphocytes recognize pathogen-associated molecular patterns (PAMPs) through pattern-recognition receptors (<xref ref-type="bibr" rid="B11">11</xref>), execute their effector functions without clonal expansion because they are not major histocompatibility complex (MHC)-restricted (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>), and present antigens to na&#x000EF;ve &#x003B1;&#x003B2; T lymphocytes (<xref ref-type="bibr" rid="B14">14</xref>). During adaptive immune responses, &#x003B3;&#x003B4; T lymphocytes develop memory responses (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B16">16</xref>), induce DC maturation (<xref ref-type="bibr" rid="B17">17</xref>), and polarize into T<sub>H</sub>1-, T<sub>H</sub>2-, T<sub>H</sub>17-, T<sub>FH</sub>-, or T<sub>REG</sub>-effector functions based on the cytokine milieu in which &#x003B3;&#x003B4; T lymphocytes encounter the antigen (<xref ref-type="bibr" rid="B17">17</xref>&#x02013;<xref ref-type="bibr" rid="B20">20</xref>). In cattle, &#x003B3;&#x003B4; T lymphocytes have shown to produce pro-inflammatory cytokines, such as IFN-&#x003B3; and IL-17A (<xref ref-type="bibr" rid="B18">18</xref>&#x02013;<xref ref-type="bibr" rid="B21">21</xref>), regulate granuloma development (<xref ref-type="bibr" rid="B22">22</xref>), have regulatory effects (<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B24">24</xref>), and modulate macrophage-effector functions (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B26">26</xref>).</p>
<p>This work focuses on studying the specific interactions of bovine &#x003B3;&#x003B4; T lymphocyte subsets with cells from the MPS in the context of <italic>Mycobacterium avium</italic> subspecies <italic>paratuberculosis</italic> (<italic>Map</italic>) infection <italic>in vitro</italic>. Macrophages and DCs are the primary host cells for <italic>Map</italic> (<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B28">28</xref>), an intracellular bacterium causing paratuberculosis, which is an important mycobacterial infection of ruminants. The disease is characterized by a long subclinical phase (&#x0003E;2&#x02009;years) (<xref ref-type="bibr" rid="B27">27</xref>), followed by a clinical phase in which animals show diarrhea and weight loss caused by inadequate nutrient absorption as a result of progressive granulomatous enteritis (<xref ref-type="bibr" rid="B29">29</xref>).</p>
<p>Both &#x003B3;&#x003B4; T lymphocytes and the MPS play critical roles during the early pathogenesis of <italic>Map</italic> infection in cattle: (1) macrophages are the preferred cell host and the main effector cell during <italic>Map</italic> infection (<xref ref-type="bibr" rid="B30">30</xref>); (2) <italic>Map</italic> also infects DCs (<xref ref-type="bibr" rid="B28">28</xref>); and (3) monocytes migrate into the intestinal tract during infection and differentiate into effector cells, presumably in the presence of both WC1<sup>&#x0002B;</sup> and WC1<sup>neg</sup> &#x003B3;&#x003B4; T lymphocyte subsets (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B31">31</xref>). Furthermore, we have previously shown that &#x003B3;&#x003B4; T lymphocytes influence autologous monocyte-derived macrophage (MDM) effector functions of young calves and heifers during <italic>Map</italic> infection <italic>in vitro</italic> (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B26">26</xref>). Therefore, the hypothesis for this study was that WC1<sup>&#x0002B;</sup> and WC1<sup>neg</sup> &#x003B3;&#x003B4; T lymphocytes of young calves influence (1) monocyte differentiation and (2) DC maturation during <italic>Map</italic> infection <italic>in vitro</italic>. The specific aims of this study were to first characterize cells from MPS of young calves and then to understand how bovine WC1<sup>&#x0002B;</sup> or WC1<sup>neg</sup> &#x003B3;&#x003B4; T lymphocytes influence autologous monocyte differentiation and DC maturation during <italic>in vitro Map</italic> infection.</p>
</sec>
<sec id="S2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="S2-1">
<title>Animals and Blood Collection</title>
<p>All animal procedures in this study were approved by the Institutional Committee on Animal Care at the University of Guelph (Animal Utilization Protocol &#x00023; 3373). All animals were randomly selected from the Elora Dairy Research Centre, where there is no official paratuberculosis herd certification program; however, the estimated prevalence is near zero in this herd, because it is under continual surveillance for <italic>Map</italic> infection by regular screening for <italic>Map</italic>-specific antibodies using ELISA. No positive antibody tests, clinical or suspect paratuberculosis cases have been diagnosed on this farm for several years. Approximately 120&#x02009;mL of blood were collected <italic>via</italic> jugular venipuncture using EDTA vacutainer tubes (BD Biosciences, Mississauga, ON, Canada) from seven healthy Holstein calves between 30 and 40&#x02009;days of age. Number of animals was selected based on sample power calculations. Additional 60&#x02009;mL of blood from the same calves were collected in serum separator vacutainer tubes (BD Biosciences). Blood samples were stored at 4&#x000B0;C and promptly transferred to the laboratory.</p>
</sec>
<sec id="S2-2">
<title>Peripheral Blood Mononuclear Cells (PBMCs), MDMs, and MDDCs</title>
<p>Under sterile conditions, whole blood was diluted (1:1) with PBS containing 0.5% BSA. PBMCs were isolated from whole blood using Histopaque 1077 (Sigma Aldrich, Oakville, ON, Canada) density gradient centrifugation, counted using a Moxi Z cell counter (Orflo, Hailey, ID, USA), and resuspended in complete medium RPMI 1640 containing 2&#x02009;mM of <sc>l</sc>-glutamine and 25&#x02009;mM of HEPES (Gibco, Carlsbad, CA, USA) supplemented with 5&#x02009;&#x000D7;&#x02009;10<sup>&#x02212;5</sup>&#x02009;M 2-mercaptoethanol (Sigma Aldrich, Oakville, ON, Canada), with penicillin (1,000&#x02009;U/mL), streptomycin sulfate (10&#x02009;mg/mL), and amphotericin B (0.25&#x02009;&#x000B5;g/mL) (Sigma Aldrich). Our source of serum was 10% autologous serum based on our previous findings that show that cells are not self-reactive to cytokines or other soluble mediators present in autologous serum (<xref ref-type="bibr" rid="B26">26</xref>). Cell suspensions were transferred to 175&#x02009;cm<sup>2</sup> flasks (Corning, Tewksbury, MA, USA) at a concentration of 7.5&#x02009;&#x000D7;&#x02009;10<sup>6</sup>/mL per flask. After 1&#x02009;h of incubation at 37&#x000B0;C in 5% CO<sub>2</sub>, non-adherent cells were collected by washing each flask 3&#x000D7; with PBS prior to lymphocyte staining and sorting. Adherent cells (monocytes) were detached from the flasks using TrypLE Express (Gibco), washed, counted, and resuspended in complete RPMI. 2&#x02009;&#x000D7;&#x02009;10<sup>5</sup> monocytes/well were cultured in 24-well flat-bottomed plates (Corning). To obtain MDMs, monocytes were incubated for 6&#x02009;days in complete RPMI. To obtain iMDDCs, complete RPMI was supplemented with 200&#x02009;ng/mL of recombinant bovine interleukin-4 (Kingfisher Biotech, MN, USA) and 100&#x02009;ng/mL of recombinant bovine GM-CSF (Kingfisher Biotech). After 6&#x02009;days of differentiation, cells were used in coculture assays as iMDDCs; some wells of iMDDCs were induced to maturity (mMDDCs) by adding 1&#x02009;&#x000B5;L/mL of <italic>Escherichia coli</italic> LPS (Sigma Aldrich) to the cell culture for 48&#x02009;h prior to use in coculture assays as previously described (<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B33">33</xref>).</p>
</sec>
<sec id="S2-3">
<title>&#x003B3;&#x003B4; T Lymphocyte Sorting</title>
<p>Non-adherent cells collected from the original flasks were resuspended in PBS containing 0.5% BSA, incubated in the dark at 4&#x000B0;C for 15&#x02009;min with WC1 &#x003B3;&#x003B4; T lymphocyte monoclonal antibody (BAQ4A, N2 epitope, IgG1, Monoclonal Antibody Center, Washington State University) and &#x003B3;&#x003B4; T cell receptor monoclonal antibody (GB21A, TCR1-N24 &#x003B4; chain-specific, IgG2b, Washington State University), washed, and incubated in the dark at 4&#x000B0;C for 15&#x02009;min with the secondary antibody PE-Cy7 (IgG1, Biolegend, San Diego, CA, USA) and DyLight 405 (IgG2b, Jackson ImmunoResearch, Suffolk, UK). After washing, stained cells were sorted by FACS (Aria IIu, BD Biosciences, Mississauga, ON, Canada). After sorting WC1<sup>&#x0002B;</sup> and WC1<sup>neg</sup> &#x003B3;&#x003B4; T cell populations, cells were resuspended in complete RPMI. The purity of each subset was verified by FACS to be 85&#x02013;95% and confirmation of a viability over 85% was assessed using the trypan blue exclusion assay described previously (<xref ref-type="bibr" rid="B34">34</xref>).</p>
</sec>
<sec id="S2-4">
<title>Cocultures</title>
<p>For monocyte differentiation assays, 1&#x02009;&#x000D7;&#x02009;10<sup>6</sup> sorted WC1<sup>&#x0002B;</sup> or WC1<sup>neg</sup> &#x003B3;&#x003B4; T lymphocytes were added directly to wells containing 2&#x02009;&#x000D7;&#x02009;10<sup>5</sup> monocytes the same day of PBMC isolation (day 0). After 6&#x02009;days, cultures of MDMs, iMDDC, monocytes differentiated in presence of WC1<sup>&#x0002B;</sup> (dMonWC1<sup>&#x0002B;</sup>), or WC1<sup>neg</sup> (dMonWC1<sup>neg</sup>) &#x003B3;&#x003B4; T lymphocytes were obtained (Figure <xref ref-type="fig" rid="F1">1</xref>). For MDDC maturation assays, 1&#x02009;&#x000D7;&#x02009;10<sup>6</sup> sorted WC1<sup>&#x0002B;</sup> or WC1<sup>neg</sup> &#x003B3;&#x003B4; T lymphocytes were added to wells containing 2&#x02009;&#x000D7;&#x02009;10<sup>5</sup> iMDDCs (day 6) for 48&#x02009;h (iMDDC&#x02009;&#x0002B;&#x02009;WC1<sup>&#x0002B;</sup> and iMDDC&#x02009;&#x0002B;&#x02009;WC1<sup>neg</sup>) (Figure <xref ref-type="fig" rid="F4">4</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p><bold>Monocyte differentiation assays</bold>. 1&#x02009;&#x000D7;&#x02009;10<sup>6</sup> WC1<sup>&#x0002B;</sup> or WC1<sup>neg</sup> &#x003B3;&#x003B4; T lymphocytes were added directly to wells containing 2&#x02009;&#x000D7;&#x02009;10<sup>5</sup> monocytes the same day of peripheral blood mononuclear cell isolation (day 0). After 6&#x02009;days of differentiation, cultures of monocyte-derived macrophages (MDMs), monocyte-derived dendritic cells (MDDCs), monocytes differentiated in presence of WC1<sup>&#x0002B;</sup> (dMonWC1<sup>&#x0002B;</sup>) or WC1<sup>neg</sup> (dMonWC1<sup>neg</sup>) &#x003B3;&#x003B4; T lymphocytes were obtained. On day 6, live <italic>Map</italic> was added at a multiplicity of infection of 10:1 to evaluate how it affected phenotype of MDMs, dMonWC1<sup>&#x0002B;</sup> and dMonWC1<sup>neg</sup>; and MDDC after 48&#x02009;h.</p></caption>
<graphic xlink:href="fimmu-08-00534-g001.tif"/>
</fig>
</sec>
<sec id="S2-5">
<title>Infection with <italic>Map</italic></title>
<p>For monocyte differentiation assays on day six MDMs, iMDDC, dMonWC1<sup>&#x0002B;</sup>, and dMonWC1<sup>neg</sup> were infected. For MDDC maturation assays, &#x003B3;&#x003B4; T lymphocyte subsets and bacterial suspensions of <italic>Map</italic> were added on day 6 to iMDDCs. Cell cultures were infected at a multiplicity of infection (MOI) of 10:1 for 48&#x02009;h with an Ontario-derived clinical bovine <italic>Map</italic> strain (gc86). The <italic>Map</italic> strain was cultured in Middlebrook 7H9 broth supplemented with 10% OADC (oleic acid, albumin, dextrose, catalase) enrichment (BD Biosciences), 0.05% Tween 80 (Sigma Aldrich), and 2&#x02009;mg/L of mycobactin J (Allied Monitor, Inc., Fayette, MO, USA) referred to below as 7H9-OADC-MJ-T. Optical density (OD) was measured with a spectrophotometer (Genesys 10S VIS, ThermoFisher Scientific, Waltham, MA, USA) at 540&#x02009;nm wavelength and quantification of bacteria was performed using a standard growth curve. The bacterial suspension was briefly sonicated with a sonic dismembrator (Model 120, Fisher Scientific) at 60% amplitude during 2&#x02009;s pulses to disperse bacterial clumps. Aliquots of <italic>Map</italic> with viability of 97.4% measured by fluorescein diacetate (Sigma Aldrich) as described previously (<xref ref-type="bibr" rid="B25">25</xref>) were kept at &#x02212;80&#x000B0;C in saline to ensure that the same <italic>Map</italic> passage was used throughout this study.</p>
</sec>
<sec id="S2-6">
<title>Antibodies and Flow Cytometry</title>
<p>Antibodies used in this study are shown in Table <xref ref-type="table" rid="T1">1</xref>. Cells were collected 48&#x02009;h after <italic>Map</italic> infection into serum-free media before staining and assessment (FACSAria IIu, BD Biosciences). Viability was assessed using Zombie NIR fixable viability kit (Biolegend, CA, USA). The acquisition software used was FACS Diva II, and data were analyzed using FlowJo software (Treestar, Inc., San Carlos, CA, USA) (Figure S2 in Supplementary Material shows gating strategy).</p>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p><bold>Anti-bovine monoclonal antibodies used for peripheral blood mononuclear cell immunophenotyping and coculture experiments</bold>.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left">Primary mAb</th>
<th valign="top" align="left">Clone</th>
<th valign="top" align="left">Isotype</th>
<th valign="top" align="left">Source</th>
<th valign="top" align="left">Secondary antibody</th>
<th valign="top" align="left">Source</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top" colspan="6"><bold>Monocyte differentiation</bold></td>
</tr>
<tr>
<td align="left" valign="top">CD11c</td>
<td align="left" valign="top">BAQ153A</td>
<td align="left" valign="top">IgM</td>
<td align="left" valign="top">WSU<xref ref-type="table-fn" rid="tfn1"><sup>a</sup></xref></td>
<td align="left" valign="top">PE/Cy7</td>
<td align="left" valign="top">Biolegend</td>
</tr>
<tr>
<td align="left" valign="top">CD163</td>
<td align="left" valign="top">LND68A</td>
<td align="left" valign="top">IgG1</td>
<td align="left" valign="top">WSU<xref ref-type="table-fn" rid="tfn1"><sup>a</sup></xref></td>
<td align="left" valign="top">Pacific Orange</td>
<td align="left" valign="top">TFS<xref ref-type="table-fn" rid="tfn2"><sup>b</sup></xref></td>
</tr>
<tr>
<td align="left" valign="top">CD11b</td>
<td align="left" valign="top">MM10A</td>
<td align="left" valign="top">IgG2b</td>
<td align="left" valign="top">WSU<xref ref-type="table-fn" rid="tfn1"><sup>a</sup></xref></td>
<td align="left" valign="top">DyLight405</td>
<td align="left" valign="top">JIR<xref ref-type="table-fn" rid="tfn3"><sup>c</sup></xref></td>
</tr>
<tr>
<td align="left" valign="top">CD14</td>
<td align="left" valign="top">CAM36A</td>
<td align="left" valign="top">IgG1</td>
<td align="left" valign="top">WSU<xref ref-type="table-fn" rid="tfn1"><sup>a</sup></xref></td>
<td align="left" valign="top">AF647<xref ref-type="table-fn" rid="tfn4"><sup>d</sup></xref></td>
<td align="left" valign="top">TFS<xref ref-type="table-fn" rid="tfn2"><sup>b</sup></xref></td>
</tr>
<tr>
<td align="left" valign="top">R-PE-conjugated anti-CD1b</td>
<td align="left" valign="top">CC20</td>
<td align="left" valign="top">IgG2a</td>
<td align="left" valign="top">BioRad</td>
<td align="left" valign="top">&#x02013;</td>
<td align="left" valign="top">&#x02013;</td>
</tr>
<tr>
<td align="left" valign="top">R-PE/Cy5-conjugated anti-CD172a</td>
<td align="left" valign="top">CC149</td>
<td align="left" valign="top">IgG2b</td>
<td align="left" valign="top">BioRad</td>
<td align="left" valign="top">&#x02013;</td>
<td align="left" valign="top">&#x02013;</td>
</tr>
<tr>
<td align="left" valign="top">FITC-conjugated anti-CD205</td>
<td align="left" valign="top">CC98</td>
<td align="left" valign="top">IgG2b</td>
<td align="left" valign="top">BioRad</td>
<td align="left" valign="top">&#x02013;</td>
<td align="left" valign="top">&#x02013;</td>
</tr>
<tr>
<td align="left" valign="top" colspan="6"><bold>Monocyte-derived dendritic cell maturation</bold></td>
</tr>
<tr>
<td align="left" valign="top">Major histocompatibility complex (MHC)-I</td>
<td align="left" valign="top">B5C</td>
<td align="left" valign="top">IgG2b</td>
<td align="left" valign="top">WSU<xref ref-type="table-fn" rid="tfn1"><sup>a</sup></xref></td>
<td align="left" valign="top">AF594</td>
<td align="left" valign="top"/>
</tr>
<tr>
<td align="left" valign="top">MHC-II</td>
<td align="left" valign="top">H42A</td>
<td align="left" valign="top">IgG2a</td>
<td align="left" valign="top">WSU<xref ref-type="table-fn" rid="tfn1"><sup>a</sup></xref></td>
<td align="left" valign="top">AF647</td>
<td align="left" valign="top"/>
</tr>
<tr>
<td align="left" valign="top">R-PE-conjugated anti-CD86</td>
<td align="left" valign="top">ILA190</td>
<td align="left" valign="top">IgG1</td>
<td align="left" valign="top">LSBio</td>
<td align="left" valign="top">&#x02013;</td>
<td align="left" valign="top">&#x02013;</td>
</tr>
<tr>
<td align="left" valign="top">FITC-conjugated anti-CD80</td>
<td align="left" valign="top">ILA159</td>
<td align="left" valign="top">IgG1</td>
<td align="left" valign="top">BioRad</td>
<td align="left" valign="top">&#x02013;</td>
<td align="left" valign="top">&#x02013;</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn1"><p><italic><sup>a</sup>Washington State University, Monoclonal Antibody Center</italic>.</p></fn>
<fn id="tfn2"><p><italic><sup>b</sup>ThermoFisher Scientific</italic>.</p></fn>
<fn id="tfn3"><p><italic><sup>c</sup>Jackson ImmunoResearch</italic>.</p></fn>
<fn id="tfn4"><p><italic><sup>d</sup>Zenon antibody labeling kit</italic>.</p></fn></table-wrap-foot></table-wrap>
</sec>
<sec id="S2-7">
<title>DQ-Ovalbumin (DQ-OVA) Endocytosis Assay</title>
<p>DQ-ovalbumin was added at a concentration of 10&#x02009;&#x000B5;g/mL to 60&#x02009;&#x000B5;L of cell suspension (2&#x02009;&#x000D7;&#x02009;10<sup>5</sup> cells) of monocytes, MDMs, iMDDCs, mMDDCs, dMonWC1<sup>&#x0002B;</sup>, dMonWC1<sup>neg</sup>, iMDDC&#x02009;&#x0002B;&#x02009;WC1<sup>&#x0002B;</sup>, or iMDDC&#x02009;&#x0002B;&#x02009;WC1<sup>neg</sup>. Cells were incubated at 37&#x000B0;C for 45&#x02009;min. After incubation, cells were washed with cold PBS and immediately analyzed by flow cytometry (FACSAria IIu, BD Biosciences) to measure the bright green fluorescence exhibited by the ovalbumin labeled with the pH-insensitive fluorescent dye, boron-dipyrromethene, upon proteolytic degradation after phagocytosis.</p>
</sec>
<sec id="S2-8">
<title><italic>Map</italic> Viability</title>
<p>Forty-eight hours after <italic>Map</italic> infection of MDMs, iMDDCs, dMonWC1<sup>&#x0002B;</sup>, or dMonWC1<sup>neg</sup>, culture supernatants were collected and wells containing <italic>Map</italic>-infected cells were washed twice with warm PBS to remove free <italic>Map</italic>. Cells were then detached from the flasks using TrypLE Express (Gibco), centrifuged at 400&#x02009;&#x000D7;&#x02009;<italic>g</italic> for 2&#x02009;min, and resuspended in sterile saline solution. Cell suspensions were stored at &#x02212;80&#x000B0;C until further analysis. After thawing, cell suspensions were vortexed vigorously for 10&#x02009;s to lyse cells, centrifuged at 400&#x02009;&#x000D7;&#x02009;<italic>g</italic> for 2&#x02009;min, resuspended in 7H9-OADC-MJ-T, and incubated in 24-well plates for 24&#x02009;h at 37&#x000B0;C in 5% CO<sub>2</sub>. Contents of each well were centrifuged at 400&#x02009;&#x000D7;&#x02009;<italic>g</italic> for 10&#x02009;min and pellets were resuspended in 100&#x02009;&#x000B5;L of saline solution in 5&#x02009;mL conical tubes. One microliter of fluorescein diacetate at a concentration of 2&#x02009;mg/mL (Sigma Aldrich) was added to each tube. After 30&#x02009;min of incubation at 37&#x000B0;C, samples were analyzed by flow cytometry (Accuri C6, BD Biosciences). Standardization of the procedure and determination of gates were performed using a standard curve generated from known proportions of live and heat-killed <italic>Map</italic> as described previously (<xref ref-type="bibr" rid="B25">25</xref>).</p>
</sec>
<sec id="S2-9">
<title>Statistical Analysis</title>
<p>Statistical comparisons were performed using analysis of variance with SAS 9.4 software (SAS Institute, Cary, NC, USA) and GraphPad Prism 6.0 (GraphPad Software, La Jolla, CA, USA). The mean and SEM were calculated in experiments containing multiple data points. A <italic>P</italic> value of &#x02264;0.05 was considered statistically significant.</p>
</sec>
</sec>
<sec id="S3">
<title>Results</title>
<sec id="S3-1">
<title>Phenotypic and Functional Characterization of Bovine Cells from the MPS Show Clear Distinctions between MDMs and MDDCs</title>
<p>To determine the expression of MPS cell markers in this study, several cell types were defined: monocytes were freshly isolated by adherence; MDMs were collected from flasks after fresh adherent monocytes were cultured for 6&#x02009;days; MDDCs were generated by adding IL-4 and GM-CSF to fresh adherent monocyte cultures (Figure <xref ref-type="fig" rid="F1">1</xref>). Monocytes display significantly lower expression (<italic>p</italic>&#x02009;&#x0003C;&#x02009;0.0001) of CD14, CD11b, CD11c, and CD172a compared with MDMs or MDDCs (Figure <xref ref-type="fig" rid="F2">2</xref>). Fresh monocytes lack expression of CD163, CD1b, and CD205. The markers that help to differentiate MDMs from MDDCs in our system are CD11b, CD163, and CD172a, which are each significantly higher on MDMs compared to MDDCs with <italic>p</italic> values of &#x0003C;0.0001, &#x0003C;0.0001, and 0.0333, respectively (Figures <xref ref-type="fig" rid="F2">2</xref>B&#x02013;D). To establish the phagocytic capacity of MPS cells in our study, monocytes, MDMs, and MDDCs were assessed with the DQ-OVA endocytosis assay. As expected, our data show that MDMs had the highest phagocytic capacity followed by MDDC (<italic>p</italic>&#x02009;&#x0003D;&#x02009;0.0418), while monocytes have minimal phagocytic activity compared with MDMs and MDDCs (<italic>p</italic>&#x02009;&#x0003C;&#x02009;0.0001 and 0.0028, respectively) (Figure <xref ref-type="fig" rid="F3">3</xref>A). To compare the ability of MDMs and MDDCs to alter <italic>Map</italic> viability, the viability of <italic>Map</italic> recovered from MDMs and MDDCs 48&#x02009;h after <italic>in vitro</italic> infection with live <italic>Map</italic> was evaluated by flow cytometry. No significant differences were found between the viability of <italic>Map</italic> harvested from MDMs and MDDCs (<italic>p</italic>&#x02009;&#x0003D;&#x02009;0.2929) (Figure <xref ref-type="fig" rid="F3">3</xref>B).</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p><bold>Surface marker expression of cells from the MPS is heterogeneous</bold>. <bold>(A)</bold> Contour plot of live cell population and flow cytometry analysis of surface expression of CD11b, CD163, CD205, CD1b, CD14, CD172a, and CD11c on monocytes, monocyte-derived macrophages (MDMs), and monocyte-derived dendritic cells (MDDCs). CD11b, CD163, and CD172a are useful surface markers to distinguish MDMs from MDDCs <bold>(B&#x02013;D)</bold>. Useful markers that distinguish MDMs from MDDCs include CD11b, CD163, and CD172a. Histograms of a representative animal are shown (<italic>n</italic>&#x02009;&#x0003D;&#x02009;7). Different letters indicate statistically significant difference (<italic>p</italic>&#x02009;&#x0003C;&#x02009;0.05).</p></caption>
<graphic xlink:href="fimmu-08-00534-g002.tif"/>
</fig> <fig id="F3" position="float">
<label>Figure 3</label>
<caption><p><bold>Cells from the MPS have a heterogeneous phagocytic capacity and the presence of WC1<sup>neg</sup> &#x003B3;&#x003B4; T lymphocytes increase the ability of differentiated monocytes to alter <italic>Mycobacterium avium</italic> subspecies <italic>paratuberculosis</italic> (<italic>Map</italic>) viability</bold>. <bold>(A)</bold> Monocyte-derived macrophages (MDMs) had the highest phagocytic capacity, followed by monocyte-derived dendritic cell (MDDC). dMonWC1<sup>&#x0002B;</sup> and dMonWC1<sup>neg</sup> showed an intermediate phagocytic activity between MDMs and MDDC. <bold>(B)</bold> <italic>Map</italic> viability measured by flow cytometry after 48&#x02009;h of infection of MDMs, MDDC, dMonWC1<sup>&#x0002B;</sup>, and dMonWC1<sup>neg</sup>. The viability of <italic>Map</italic> harvested from dMonWC1<sup>neg</sup> was significantly lower compared to MDMs, MDDC, and dMonWC1<sup>&#x0002B;</sup>. Results are individual animal data points and means&#x02009;&#x000B1;&#x02009;SEM of seven animals. Different letters indicate statistically significant difference (<italic>p</italic>&#x02009;&#x0003C;&#x02009;0.05).</p></caption>
<graphic xlink:href="fimmu-08-00534-g003.tif"/>
</fig>
</sec>
<sec id="S3-2">
<title>The Presence of &#x003B3;&#x003B4; T Lymphocytes during Monocyte Differentiation Does Not Affect Phenotype or Phagocytic Capacity; However, Viability of <italic>Map</italic> Recovered from dMonWC1<sup>neg</sup> Was Significantly Lower</title>
<p>To analyze the effect of WC1<sup>&#x0002B;</sup> or WC1<sup>neg</sup> &#x003B3;&#x003B4; T lymphocyte subsets on monocytes during differentiation, sorted WC1<sup>&#x0002B;</sup> or WC1<sup>neg</sup> &#x003B3;&#x003B4; T lymphocytes were added to freshly isolated autologous monocytes, and the cells were left in direct contact for 6&#x02009;days prior to assessment of MPS surface-marker expression (Figure <xref ref-type="fig" rid="F1">1</xref>). Our data show that the phenotype of monocytes differentiated after 6&#x02009;days in presence of either WC1<sup>&#x0002B;</sup> or WC1<sup>neg</sup> &#x003B3;&#x003B4; T lymphocytes (dMonWC1<sup>&#x0002B;</sup> and dMonWC1<sup>neg</sup>) was not significantly different from the phenotype of monocytes differentiated without &#x003B3;&#x003B4; T lymphocytes (MDMs) in our system. The mean and SD median fluorescence intensity (MFI) of surface markers of MPS in this study are shown in Table S1 in Supplementary Material. The phagocytic capacity of dMonWC1<sup>&#x0002B;</sup> and dMonWC1<sup>neg</sup> was assessed with the DQ-OVA endocytosis assay. dMonWC1<sup>&#x0002B;</sup> and dMonWC1<sup>neg</sup> showed an intermediate phagocytic activity between MDMs (<italic>p</italic>&#x02009;&#x0003D;&#x02009;0.5403 and 0.1582, respectively) and MDDC (<italic>p</italic>&#x02009;&#x0003D;&#x02009;0.3165 and 0.8772, respectively) (Figure <xref ref-type="fig" rid="F3">3</xref>A). To determine the ability of dMonWC1<sup>&#x0002B;</sup> and dMonWC1<sup>neg</sup> to alter <italic>Map</italic> viability, the viability of <italic>Map</italic> recovered from these cells 48&#x02009;h after live <italic>Map</italic> infection was evaluated by flow cytometry. The viability of <italic>Map</italic> harvested from dMonWC1<sup>neg</sup> was significantly lower compared with the viability of <italic>Map</italic> harvested from either MDMs (<italic>p</italic>&#x02009;&#x0003D;&#x02009;0.0492), MDDC (<italic>p</italic>&#x02009;&#x0003D;&#x02009;0.0044), or dMonWC1<sup>&#x0002B;</sup> (<italic>p</italic>&#x02009;&#x0003D;&#x02009;0.0277) (Figure <xref ref-type="fig" rid="F3">3</xref>B).</p>
</sec>
<sec id="S3-3">
<title>Presence of Live <italic>Map</italic> Does Not Alter Phenotype or Functions of Cells from the MPS</title>
<p>To determine the effect of the presence of <italic>Map</italic> on the phenotype of MPS cells in this system, <italic>Map</italic> was added to cultures of MDMs, MDDC, dMonWC1<sup>&#x0002B;</sup>, and dMonWC1<sup>neg</sup> for 48&#x02009;h (Figure <xref ref-type="fig" rid="F1">1</xref>). The effect of the presence of <italic>Map</italic> was examined by comparing the same cell type (i.e., uninfected MDMs vs. <italic>Map-</italic>infected MDMs). Our data show that infection of MDMs, MDDCs, dMonWC1<sup>&#x0002B;</sup>, or dMonWC1<sup>neg</sup> with <italic>Map</italic> did not significantly alter surface expression of CD163, CD1b, CD205, CD14, CD172a, CD11b, or CD11c at 48&#x02009;h post infection (Table S1 in Supplementary Material).</p>
</sec>
<sec id="S3-4">
<title>MDDC Maturation Is Characterized by Upregulation of Surface Expression of MHC-I, CD80, and CD86, and Significant Reduction in Phagocytic Capacity</title>
<p>To examine the DC maturation process, iMDDCs were generated by adding IL-4 and GM-CSF to fresh peripheral blood-derived adherent monocyte cultures and their maturation was then induced by adding LPS for 48&#x02009;h (Figure <xref ref-type="fig" rid="F4">4</xref>). As expected, our data showed that expression of MHC-I, CD80, and CD86 were significantly higher on mMDDCs compared with iMMDCs (Figure <xref ref-type="fig" rid="F5">5</xref>, <italic>p</italic>&#x02009;&#x0003D;&#x02009;0.0105, &#x0003C;0.0001, and 0.0002, respectively); however, expression of MHC-II on mMDDCs was not significantly different from iMDDCs (<italic>p</italic>&#x02009;&#x0003D;&#x02009;0.0640) (Figure <xref ref-type="fig" rid="F5">5</xref>). To study the effect of maturation of MDDCs on their phagocytic capacity, a DQ-OVA phagocytosis assay was performed on iMDDCs and mMDDCs using flow cytometry. Our data showed that the phagocytic capacity of mMDDCs was significantly reduced compared with iMDDCs (<italic>p</italic>&#x02009;&#x02264;&#x02009;0.0001, Figure <xref ref-type="fig" rid="F6">6</xref>).</p>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption><p><bold>Dendritic cell maturation assays</bold>. Immature monocyte-derived dendritic cells (iMDDCs) were generated by adding IL-4 and GM-CSF to fresh monocyte cultures. After 6&#x02009;days of differentiation, 1&#x02009;&#x000D7;&#x02009;10<sup>6</sup> sorted &#x003B3;&#x003B4; T lymphocytes were added to wells containing 2&#x02009;&#x000D7;&#x02009;10<sup>5</sup> iMDDCs for 48&#x02009;h (iMDDC&#x02009;&#x0002B;&#x02009;WC1<sup>&#x0002B;</sup> and iMDDC&#x02009;&#x0002B;&#x02009;WC1<sup>neg</sup>). On day 6, live <italic>Mycobacterium avium</italic> subspecies <italic>paratuberculosis</italic> was added at a multiplicity of infection of 10:1 to evaluate if it affected iMDDC maturation after 48&#x02009;h.</p></caption>
<graphic xlink:href="fimmu-08-00534-g004.tif"/>
</fig>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption><p><bold>Monocyte-derived dendritic cells (MDDCs) upregulate surface expression of major histocompatibility complex (MHC)-I, CD80, and CD86 during maturation</bold>. Contour plot of live cell population and flow cytometry analysis of surface expressions of MHC-I, MHC-II, CD80, and CD86 on immature MDDCs and mature MDDCs. Histograms of a representative animal are shown (<italic>n</italic>&#x02009;&#x0003D;&#x02009;7).</p></caption>
<graphic xlink:href="fimmu-08-00534-g005.tif"/>
</fig> <fig id="F6" position="float">
<label>Figure 6</label>
<caption><p><bold>&#x003B3;&#x003B4; T lymphocytes induce monocyte-derived dendritic cell (MDDC) maturation</bold>. DQ-ovalbumin endocytosis assay on immature MDDC (iMDDC), mature MDDC (mMDDC), iMDDC&#x02009;&#x0002B;&#x02009;WC1<sup>&#x0002B;</sup>, and iMDDC&#x02009;&#x0002B;&#x02009;WC1<sup>neg</sup>. iMDDC&#x02009;&#x0002B;&#x02009;WC1<sup>&#x0002B;</sup> and iMDDC&#x02009;&#x0002B;&#x02009;WC1<sup>neg</sup> had a reduction in their phagocytic ability in the same proportion as mMDDC. Results are individual animal data points and means&#x02009;&#x000B1;&#x02009;SEM of seven animals. Different letters indicate statistically significant difference (<italic>p</italic>&#x02009;&#x0003C;&#x02009;0.05).</p></caption>
<graphic xlink:href="fimmu-08-00534-g006.tif"/>
</fig>
</sec>
<sec id="S3-5">
<title>WC1<sup>neg</sup> &#x003B3;&#x003B4; T Lymphocytes Increase MHC-II Expression on iMDDCs and Both &#x003B3;&#x003B4; T Lymphocyte Subsets Reduce Phagocytic Capacity of iMDDCs</title>
<p>To determine the effect of WC1<sup>&#x0002B;</sup> and WC1<sup>neg</sup> &#x003B3;&#x003B4; T lymphocytes on maturation of MDDCs, sorted &#x003B3;&#x003B4; T lymphocyte subsets were added to iMDDCs for 48&#x02009;h (Figure <xref ref-type="fig" rid="F4">4</xref>). iMDDC&#x02009;&#x0002B;&#x02009;WC1<sup>neg</sup> had significantly increased expression of MHC-II compared with both iMDDC (<italic>p</italic>&#x02009;&#x0003D;&#x02009;0.0013) and mMDDC (<italic>p</italic>&#x02009;&#x0003D;&#x02009;0.0046) (Figure <xref ref-type="fig" rid="F7">7</xref>). Presence of &#x003B3;&#x003B4; T lymphocytes did not affect the expression of CD80, CD86, and MHC-I on mMDDCs at 48&#x02009;h post <italic>Map</italic> infection (data not shown). An interesting finding was increased individual variation of expression of MHC-II on mMDDCs compared with all iMDDCs, iMDDC&#x02009;&#x0002B;&#x02009;WC1<sup>&#x0002B;</sup>, and iMDDC&#x02009;&#x0002B;&#x02009;WC1<sup>neg</sup>, which may suggest that the DC maturation process varies widely between animals. To study the effects of WC1<sup>&#x0002B;</sup> and WC1<sup>neg</sup> &#x003B3;&#x003B4; T lymphocytes on the maturation of MDDCs, &#x003B3;&#x003B4; T lymphocytes were added to cultures of iMDDC for 48&#x02009;h and then the DQ-OVA phagocytosis assay was performed using flow cytometry to measure changes in phagocytic ability. iMDDCs cultured in the presence of either WC1<sup>&#x0002B;</sup> or WC1<sup>neg</sup> &#x003B3;&#x003B4; T lymphocytes had significantly reduced phagocytic ability compared to iMDDCs cultured without &#x003B3;&#x003B4; T lymphocytes (<italic>p</italic>&#x02009;&#x0003D;&#x02009;0.0111 and 0.0174, respectively) (Figure <xref ref-type="fig" rid="F6">6</xref>). These findings indicate that both &#x003B3;&#x003B4; T lymphocyte subsets reduce phagocytosis by iMDDCs in our model.</p>
<fig id="F7" position="float">
<label>Figure 7</label>
<caption><p><bold>WC1<sup>neg</sup> &#x003B3;&#x003B4; T lymphocytes increase the antigen presenting ability of immature monocyte-derived dendritic cells (iMDDCs)</bold>. Median fluorescence intensity of major histocompatibility complex-II on iMDDCs, mature MDDCs, iMDDCs&#x02009;&#x0002B;&#x02009;WC1<sup>&#x0002B;</sup>, and iMDDCs&#x02009;&#x0002B;&#x02009;WC1<sup>neg</sup>. Results are individual animal data points and means&#x02009;&#x000B1;&#x02009;SEM of seven animals. Different letters indicate statistically significant difference (<italic>p</italic>&#x02009;&#x0003C;&#x02009;0.05).</p></caption>
<graphic xlink:href="fimmu-08-00534-g007.tif"/>
</fig>
</sec>
<sec id="S3-6">
<title>Live <italic>Map</italic> Was Associated with Significantly Increased Expression of MHC-I on iMDDC&#x02009;&#x0002B;&#x02009;WC1<sup>neg</sup></title>
<p>To determine the effect of <italic>Map</italic> on maturation of MDDCs, live <italic>Map</italic> was added to cultures of iMDDC, iMDDC&#x02009;&#x0002B;&#x02009;WC1<sup>&#x0002B;</sup>, and iMDDC&#x02009;&#x0002B;&#x02009;WC1<sup>neg</sup> for 48&#x02009;h (Figure <xref ref-type="fig" rid="F4">4</xref>). The presence of live <italic>Map</italic> was associated with significantly increased expression of MHC-I on iMDDC&#x02009;&#x0002B;&#x02009;WC1<sup>neg</sup> compared to iMDDC&#x02009;&#x0002B;&#x02009;WC1<sup>neg</sup> unexposed to <italic>Map</italic> (<italic>p</italic>&#x02009;&#x0003D;&#x02009;0.0090) (Figure <xref ref-type="fig" rid="F8">8</xref>). The presence of live <italic>Map</italic> did not affect the expression of CD80, CD86, and MHC-II on MDDCs at 48&#x02009;h post <italic>Map</italic> infection (data not shown).</p>
<fig id="F8" position="float">
<label>Figure 8</label>
<caption><p><bold>Live <italic>Mycobacterium avium</italic> subspecies <italic>paratuberculosis</italic> (<italic>Map</italic>) was associated with significantly increased expression of major histocompatibility complex (MHC)-I on immature monocyte-derived dendritic cell (iMDDC)&#x02009;&#x0002B;&#x02009;WC1<sup>neg</sup></bold>. Infection with live <italic>Map</italic> was associated with significantly increased expression of MHC-I on iMDDC&#x02009;&#x0002B;&#x02009;WC1<sup>neg</sup>. Median fluorescence intensity of MHC-I on iMDDCs, iMDDCs&#x02009;&#x0002B;&#x02009;WC1<sup>&#x0002B;</sup>, and iMDDCs&#x02009;&#x0002B;&#x02009;WC1<sup>neg</sup>. Results are individual animal data points and means&#x02009;&#x000B1;&#x02009;SEM of seven animals. Different letters indicate statistically significant difference (<italic>p</italic>&#x02009;&#x0003C;&#x02009;0.05).</p></caption>
<graphic xlink:href="fimmu-08-00534-g008.tif"/>
</fig>
</sec>
</sec>
<sec id="S4" sec-type="discussion">
<title>Discussion</title>
<p>During the development of host responses against pathogens, monocytes are recruited to the site of infection where they differentiate into effector cells amidst crosstalk with resident tissue immune cells (<xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B36">36</xref>). After encountering an antigen, immature DCs begin their maturation process, migrate to local draining lymph nodes where they present antigen to na&#x000EF;ve T lymphocytes to initiate, or perpetuate antigen-specific immune responses (<xref ref-type="bibr" rid="B37">37</xref>, <xref ref-type="bibr" rid="B38">38</xref>). &#x003B3;&#x003B4; T lymphocytes are resident sentinel cells in a variety of mucosal surfaces but especially in the ileum, where infection with <italic>Map</italic> is generally assumed to initially occur (<xref ref-type="bibr" rid="B39">39</xref>). In this study, we sought to first define and characterize MPS cells from young calves; using that information, we then set out to determine how WC1<sup>&#x0002B;</sup> and WC1<sup>neg</sup> &#x003B3;&#x003B4; T lymphocytes affect (1) monocyte differentiation and (2) DC maturation, both processes important to initiation and propagation of effective immune responses during infection by <italic>Map</italic> and other pathogens. For monocyte differentiation experiments, sorted peripheral blood derived WC1<sup>&#x0002B;</sup> or WC1<sup>neg</sup> &#x003B3;&#x003B4; T lymphocytes were cocultured with freshly isolated autologous monocytes for 6&#x02009;days so that their phenotype and function could be compared with the experimental controls previously defined: monocytes, MDMs, and MDDCs. For DC maturation experiments, sorted peripheral blood WC1<sup>&#x0002B;</sup> or WC1<sup>neg</sup> &#x003B3;&#x003B4; T lymphocytes were cocultured for 48&#x02009;h with iMDDCs and then compared with iMDDCs (without &#x003B3;&#x003B4; T lymphocytes) and mMDDCs (obtained after stimulation of iMDDCs with LPS for 48&#x02009;h).</p>
<p>Cells from the MPS share precursors as well as several surface markers and functions which makes it difficult to clearly distinguish between them (<xref ref-type="bibr" rid="B6">6</xref>). We show that freshly isolated peripheral blood monocytes express low levels of CD14, CD11b, CD11c, and CD172a and lack expression of CD163, CD1b, and CD205. These data are consistent with a recent review showing that bovine monocytes express CD172a but lack expression of CD1b and CD205 [reviewed in Ref. (<xref ref-type="bibr" rid="B8">8</xref>)]. Other studies have defined three distinct phenotypic bovine monocyte subsets based on their variable surface expression of CD14 and CD16 among CD172a<sup>&#x0002B;</sup> cells (<xref ref-type="bibr" rid="B40">40</xref>). Expression of CD11c and CD172a is considered constitutive in bovine monocyte subsets, while expression of CD11b is variable (<xref ref-type="bibr" rid="B41">41</xref>). We did not find significant expression of CD163 on monocytes in our study; however, expression of CD163 has been described by others in bovine monocytes (<xref ref-type="bibr" rid="B41">41</xref>). A possible explanation for these contradictory findings is the utilization of different clones of the CD163 monoclonal antibody. We used a murine anti-bovine clone (LND68A) while Corripio-Miyar et al. (<xref ref-type="bibr" rid="B41">41</xref>) used human clone (EDHu-1); potential concerns regarding interspecies cross-reactivity of monoclonal antibodies have been published (<xref ref-type="bibr" rid="B42">42</xref>).</p>
<p>In our model CD1b, CD11c, CD14, and CD205 were all upregulated following <italic>in vitro</italic> differentiation of monocytes; however, these particular markers do not reliably distinguish MDMs from MDDCs. Our data do suggest that MDMs can be phenotypically distinguished from MDDCs because of significantly higher expression of CD11b, CD163, and CD172a on MDMs compared to MDDCs. Bovine MDDCs have been described as CD172a<sup>&#x0002B;</sup> while the expression of CD1b, CD11b, CD14, and CD205 vary depending on the subset of MDDC [reviewed in Ref. (<xref ref-type="bibr" rid="B8">8</xref>)]. MDMs have historically been classified by phenotype and function using surface-marker expression and cytokine-secretion profiles, respectively, but more recently classification of MDMs as either classically (M1) and alternatively activated (M2) macrophages using expression of CD163 has been described. M1 macrophages are CD163<sup>&#x02212;</sup> and secrete pro-inflammatory cytokines while M2 macrophages are CD163<sup>&#x0002B;</sup> and secrete low levels of pro-inflammatory cytokines and high levels of IL-10 (<xref ref-type="bibr" rid="B43">43</xref>). In our <italic>in vitro</italic> model, we neither identified CD163<sup>&#x02212;</sup> populations of MDMs nor assessed cytokine concentration in supernatants. Thus, further research is required to characterize and classify cells of the bovine MPS under different isolation (a.k.a. magnetic beads, FACS, adherence), culture conditions <italic>in vitro</italic> and evaluating other relevant surface markers such as CD209 (DC-SIGN) (<xref ref-type="bibr" rid="B44">44</xref>), CD16 (<xref ref-type="bibr" rid="B41">41</xref>), CD68 (<xref ref-type="bibr" rid="B45">45</xref>), and CD11a (<xref ref-type="bibr" rid="B46">46</xref>). Regardless, our data support the basic hypothesis that MPS cells comprise a complex network of distinct cell subsets that though they share some overlapping phenotypic and functional characteristics, they polarize depending on the local microenvironment for specific functions (<xref ref-type="bibr" rid="B47">47</xref>).</p>
<p>After coculturing freshly isolated blood monocytes with sorted WC1<sup>&#x0002B;</sup> and WC1<sup>neg</sup> &#x003B3;&#x003B4; T lymphocytes (dMonWC1<sup>&#x0002B;</sup> and dMonWC1<sup>neg</sup>, respectively) during the differentiation process, our data indicate that the presence of &#x003B3;&#x003B4; T lymphocytes has no phenotype-altering effect on monocyte differentiation. Viability of <italic>Map</italic> recovered from dMonWC1<sup>neg</sup>, however, was significantly reduced suggesting that the presence of WC1<sup>neg</sup> &#x003B3;&#x003B4; T lymphocytes improves the ability of differentiated monocytes (dMonWC1<sup>neg</sup>) to limit <italic>Map</italic> viability. In a previous study, we showed that the presence of either WC1<sup>&#x0002B;</sup> or WC1<sup>neg</sup> &#x003B3;&#x003B4; T lymphocytes cocultured with autologous <italic>Map</italic>-infected MDMs from 30- to 40-day-old calves was associated with reduced viability of <italic>Map</italic> recovered from MDMs (<xref ref-type="bibr" rid="B26">26</xref>). Taking into account that (1) in the previous study, MDMs were considered fully differentiated prior to the addition of &#x003B3;&#x003B4; T lymphocytes into cocultures, (2) in the current study, significant differences were observed between the viability of <italic>Map</italic> recovered from dMonWC1<sup>&#x0002B;</sup> and dMonWC1<sup>neg</sup>, and (3) when <italic>Map</italic> was introduced in the current study, WC1<sup>&#x0002B;</sup> and WC1<sup>neg</sup> &#x003B3;&#x003B4; T lymphocytes had been removed; we hypothesize that dMonWC1<sup>neg</sup> are distinct from classical MDMs, and that WC1<sup>neg</sup> &#x003B3;&#x003B4; T lymphocytes alter the functional differentiation of peripheral blood monocytes. Based on these data, our hypothesis is that WC1<sup>neg</sup> &#x003B3;&#x003B4; T lymphocytes have a direct effect on transcription factor expression during monocyte differentiation resulting in a monocyte-derived cell with increased ability to limit <italic>Map</italic> viability. Because we have observed that the number of &#x003B3;&#x003B4; T lymphocyte subsets within tissues of mucosal surfaces is variable between calves (unpublished data), we hypothesize that inter-animal variability also influences the different immune responses and disease outcomes that can be commonly observed within groups of calves (i.e., a herd with endemic <italic>Map</italic> infection). This inter-animal variability might explain why some animals (i.e., those with more WC1<sup>neg</sup> &#x003B3;&#x003B4; T lymphocytes or those that have more cognate &#x003B3;&#x003B4; T lymphocyte/MPS cell interactions in the ileum) clear <italic>Map</italic> infection and do not progress to later stages of bovine paratuberculosis. Further studies are required to characterize the distribution and function of bovine &#x003B3;&#x003B4; T lymphocytes in different mucosal and non-mucosal tissues.</p>
<p>To determine how &#x003B3;&#x003B4; T lymphocyte subsets affect DC maturation, we first defined the characteristics of both iMDDC and mMDDC in our system by evaluating expression of specific maturation markers and co-stimulatory molecules. As expected and based on the current literature, our data confirm that MHC-I, CD80, and CD86 are useful markers to differentiate mMDDCs from iMDDCS because they are upregulated during the maturation process. Other bovine models have shown that <italic>Salmonella typhimurium</italic>-infected DCs had significantly increased expression of MHC-I, MHC-II, CD40, CD80, and CD86 (<xref ref-type="bibr" rid="B48">48</xref>). In our system, MHC-II was not upregulated on mMDDCs at 48&#x02009;h post <italic>Map</italic> infection; however, the expression of MHC-II was highly variable between animals in our study. Inter-animal immune cell phenotypic variability has been well established in bovine studies of our lab and others (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B49">49</xref>), and the distinct pattern of high/low-effector functions and specific phenotypes in cattle is complex but probably explains an individual&#x02019;s unique ability to respond (or not) to infection. Timing may also have influenced our ability to detect early and transient changes in MHC-II expression. It is known that after stimulation of murine DC PAMPs receptors, MHC-II expression increases transiently but then decreases (<xref ref-type="bibr" rid="B50">50</xref>), though this phenomenon has not been shown in bovine DCs. Furthermore, it is known that MHC-II expression on bovine MDMs is downregulated between 24 and 48&#x02009;h post <italic>Map</italic> infection (<xref ref-type="bibr" rid="B51">51</xref>) and because cells in this study were analyzed at only a single time point (48&#x02009;h after <italic>Map</italic> infection), we may have thus been unable to detect early differences in the expression of MHC-II due to timing.</p>
<p>The presence of WC1<sup>neg</sup> &#x003B3;&#x003B4; T lymphocytes in our coculture experiment was associated with significantly increased expression of MHC-II on iMDDC&#x02009;&#x0002B;&#x02009;WC1<sup>neg</sup> cells compared with iMDDCs and mMDDCs. Upregulation of MHC-II, along with CD86 and CD83 has also been induced by human V&#x003B3;9V&#x003B4;2 T lymphocytes on DCs, suggesting the ability of &#x003B3;&#x003B4; T lymphocytes to specifically promote DC maturation (<xref ref-type="bibr" rid="B17">17</xref>). Furthermore, human iMDDCs induce V&#x003B3;9V&#x003B4;2 T lymphocytes to secrete pro-inflammatory cytokines required for their own maturation (<xref ref-type="bibr" rid="B52">52</xref>). This reciprocal effect has not been definitively demonstrated in cattle, and further research is required to determine if bovine DCs could induce this effect on either WC1<sup>&#x0002B;</sup> and/or WC1<sup>neg</sup> &#x003B3;&#x003B4; T lymphocytes.</p>
<p>A major functional change during MDDC maturation is reduced phagocytic capacity of MDDCs; this finding is supported by studies in adult cows (<xref ref-type="bibr" rid="B28">28</xref>). In our study, a reduced phagocytic capacity was observed in iMMDCs cocultured with either WC1<sup>&#x0002B;</sup> or WC1<sup>neg</sup> &#x003B3;&#x003B4; T lymphocyte subsets, which suggests that WC1<sup>&#x0002B;</sup> or WC1<sup>neg</sup> &#x003B3;&#x003B4; T lymphocytes induce &#x0201C;functional&#x0201D; MDDC maturation with respect to phagocytic capacity.</p>
<p>Our overall hypothesis was that early &#x003B3;&#x003B4; T lymphocytes/MPS/<italic>Map</italic> interactions influence the initiation of early local host immunity and potentially the induction of adaptive immunity and progression or eventual outcome of <italic>Map</italic> infection. To test our hypothesis, we first needed to define the phenotype and effector functions of MPS cells specifically under <italic>in vitro</italic> conditions in our laboratory. We have shown that cells from the MPS can be distinguished by collective examination of phenotype and function: (1) monocytes lack the expression of CD1b, CD205, and CD163; (2) MDMs express higher levels of CD11b, CD163, and CD172a compared to MDDCs; (3) mMDDCs express higher levels of CD11c, CD80, and CD86 compared to iMDDC; mMDDCs have reduced phagocytic capacity compared to iMDDCs. In this study, the most significant findings related to the effect of &#x003B3;&#x003B4; T lymphocytes include: (1) the presence of WC1<sup>neg</sup> &#x003B3;&#x003B4; T lymphocytes contributes to differentiation of monocytes into cells with increased ability to limit <italic>Map</italic> viability and (2) both &#x003B3;&#x003B4; T lymphocyte subsets induce functional MDDC maturation (reduced phagocytosis).</p>
</sec>
<sec id="S5">
<title>Ethics Statement</title>
<p>All animal procedures in this study were approved by the Institutional Committee on Animal Care at the University of Guelph (Animal Utilization Protocol &#x00023; 3373).</p>
</sec>
<sec id="S6" sec-type="author-contributor">
<title>Author Contributions</title>
<p>MMB and BLP performed the experiments; designed the experiments; interpreted the data; drafted the manuscript; reviewed and approved the final version of the manuscript; agreed to be accountable for the content of the work.</p>
</sec>
<sec id="S7">
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ack>
<p>We thank John F. Prescott, Lucy Mutharia, Stefan Keller and Shayan Sharif for their scientific advice and Laura Wright for her collaboration during the blood collection.</p>
</ack>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This work was funded by The National Science and Engineering Research Council (NSERC) of Canada. We acknowledge The Vanier Canada Graduate Scholarship and the Colombian Administrative Department of Science, Technology and Innovation (Colciencias) for their financial assistance.</p></fn>
</fn-group>
<sec id="S9" sec-type="supplementary-material">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at <uri xlink:href="http://journal.frontiersin.org/article/10.3389/fimmu.2017.00534/full&#x00023;supplementary-material">http://journal.frontiersin.org/article/10.3389/fimmu.2017.00534/full&#x00023;supplementary-material</uri>.</p>
<supplementary-material xlink:href="Data_Sheet_1.PDF" id="SM1" mimetype="applicationn/PDF" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hume</surname> <given-names>DA</given-names></name></person-group>. <article-title>The mononuclear phagocyte system</article-title>. <source>Curr Opin Immunol</source> (<year>2006</year>) <volume>18</volume>:<fpage>49</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="doi">10.1016/j.coi.2005.11.008</pub-id><pub-id pub-id-type="pmid">16338128</pub-id></citation></ref>
<ref id="B2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hume</surname> <given-names>DA</given-names></name> <name><surname>Ross</surname> <given-names>IL</given-names></name> <name><surname>Himes</surname> <given-names>SR</given-names></name> <name><surname>Sasmono</surname> <given-names>RT</given-names></name> <name><surname>Wells</surname> <given-names>CA</given-names></name> <name><surname>Ravasi</surname> <given-names>T</given-names></name></person-group>. <article-title>The mononuclear phagocyte system revisited</article-title>. <source>J Leukoc Biol</source> (<year>2002</year>) <volume>72</volume>:<fpage>621</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">12377929</pub-id></citation></ref>
<ref id="B3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>L</given-names></name> <name><surname>Li</surname> <given-names>CL</given-names></name> <name><surname>Shortman</surname> <given-names>K</given-names></name></person-group>. <article-title>Thymic dendritic cell precursors: relationship to the T lymphocyte lineage and phenotype of the dendritic cell progeny</article-title>. <source>J Exp Med</source> (<year>1996</year>) <volume>184</volume>:<fpage>903</fpage>&#x02013;<lpage>11</lpage>.<pub-id pub-id-type="doi">10.1084/jem.184.3.903</pub-id><pub-id pub-id-type="pmid">9064350</pub-id></citation></ref>
<ref id="B4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Manz</surname> <given-names>MG</given-names></name> <name><surname>Traver</surname> <given-names>D</given-names></name> <name><surname>Akashi</surname> <given-names>K</given-names></name> <name><surname>Merad</surname> <given-names>M</given-names></name> <name><surname>Miyamoto</surname> <given-names>T</given-names></name> <name><surname>Engleman</surname> <given-names>EG</given-names></name> <etal/></person-group> <article-title>Dendritic cell development from common myeloid progenitors</article-title>. <source>Ann N Y Acad Sci</source> (<year>2001</year>) <volume>938</volume>:<fpage>167</fpage>&#x02013;<lpage>73; discussion 173&#x02013;4</lpage>.<pub-id pub-id-type="doi">10.1111/j.1749-6632.2001.tb03586.x</pub-id><pub-id pub-id-type="pmid">11458504</pub-id></citation></ref>
<ref id="B5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jenkins</surname> <given-names>SJ</given-names></name> <name><surname>Hume</surname> <given-names>DA</given-names></name></person-group>. <article-title>Homeostasis in the mononuclear phagocyte system</article-title>. <source>Trends Immunol</source> (<year>2014</year>) <volume>35</volume>:<fpage>358</fpage>&#x02013;<lpage>67</lpage>.<pub-id pub-id-type="doi">10.1016/j.it.2014.06.006</pub-id><pub-id pub-id-type="pmid">25047416</pub-id></citation></ref>
<ref id="B6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Strauss</surname> <given-names>O</given-names></name> <name><surname>Dunbar</surname> <given-names>PR</given-names></name> <name><surname>Bartlett</surname> <given-names>A</given-names></name> <name><surname>Phillips</surname> <given-names>A</given-names></name></person-group>. <article-title>The immunophenotype of antigen presenting cells of the mononuclear phagocyte system in normal human liver&#x02014;a systematic review</article-title>. <source>J Hepatol</source> (<year>2015</year>) <volume>62</volume>:<fpage>458</fpage>&#x02013;<lpage>68</lpage>.<pub-id pub-id-type="doi">10.1016/j.jhep.2014.10.006</pub-id></citation></ref>
<ref id="B7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haniffa</surname> <given-names>M</given-names></name> <name><surname>Bigley</surname> <given-names>V</given-names></name> <name><surname>Collin</surname> <given-names>M</given-names></name></person-group>. <article-title>Human mononuclear phagocyte system reunited</article-title>. <source>Semin Cell Dev Biol</source> (<year>2015</year>) <volume>41</volume>:<fpage>59</fpage>&#x02013;<lpage>69</lpage>.<pub-id pub-id-type="doi">10.1016/j.semcdb.2015.05.004</pub-id><pub-id pub-id-type="pmid">25986054</pub-id></citation></ref>
<ref id="B8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Summerfield</surname> <given-names>A</given-names></name> <name><surname>Auray</surname> <given-names>G</given-names></name> <name><surname>Ricklin</surname> <given-names>M</given-names></name></person-group>. <article-title>Comparative dendritic cell biology of veterinary mammals</article-title>. <source>Annu Rev Anim Biosci</source> (<year>2015</year>) <volume>3</volume>:<fpage>533</fpage>&#x02013;<lpage>57</lpage>.<pub-id pub-id-type="doi">10.1146/annurev-animal-022114-111009</pub-id></citation></ref>
<ref id="B9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rogers</surname> <given-names>AN</given-names></name> <name><surname>Vanburen</surname> <given-names>DG</given-names></name> <name><surname>Hedblom</surname> <given-names>EE</given-names></name> <name><surname>Tilahun</surname> <given-names>ME</given-names></name> <name><surname>Telfer</surname> <given-names>JC</given-names></name> <name><surname>Baldwin</surname> <given-names>CL</given-names></name></person-group>.<article-title>Gammadelta T cell function varies with the expressed WC1 coreceptor</article-title>. <source>J Immunol</source> (<year>2005</year>) <volume>174</volume>:<fpage>3386</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.174.6.3386</pub-id><pub-id pub-id-type="pmid">15749871</pub-id></citation></ref>
<ref id="B10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hedges</surname> <given-names>JF</given-names></name> <name><surname>Cockrell</surname> <given-names>D</given-names></name> <name><surname>Jackiw</surname> <given-names>L</given-names></name> <name><surname>Meissner</surname> <given-names>N</given-names></name> <name><surname>Jutila</surname> <given-names>MA</given-names></name></person-group>. <article-title>Differential mRNA expression in circulating gammadelta T lymphocyte subsets defines unique tissue-specific functions</article-title>. <source>J Leukoc Biol</source> (<year>2003</year>) <volume>73</volume>:<fpage>306</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="doi">10.1189/jlb.0902453</pub-id><pub-id pub-id-type="pmid">12554808</pub-id></citation></ref>
<ref id="B11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hedges</surname> <given-names>JF</given-names></name> <name><surname>Lubick</surname> <given-names>KJ</given-names></name> <name><surname>Jutila</surname> <given-names>MA</given-names></name></person-group>. <article-title>&#x003B3;&#x003B4; T cells respond directly to pathogen-associated molecular patterns</article-title>. <source>J Immunol</source> (<year>2005</year>) <volume>174</volume>:<fpage>6045</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.174.10.6045</pub-id></citation></ref>
<ref id="B12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vantourout</surname> <given-names>P</given-names></name> <name><surname>Hayday</surname> <given-names>A</given-names></name></person-group>. <article-title>Six-of-the-best: unique contributions of &#x003B3;&#x003B4; T cells to immunology</article-title>. <source>Nat Rev Immunol</source> (<year>2013</year>) <volume>13</volume>:<fpage>88</fpage>&#x02013;<lpage>100</lpage>.<pub-id pub-id-type="doi">10.1038/nri3384</pub-id><pub-id pub-id-type="pmid">23348415</pub-id></citation></ref>
<ref id="B13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname> <given-names>Y</given-names></name> <name><surname>Morita</surname> <given-names>CT</given-names></name> <name><surname>Tanaka</surname> <given-names>Y</given-names></name> <name><surname>Nieves</surname> <given-names>E</given-names></name> <name><surname>Brenner</surname> <given-names>MB</given-names></name> <name><surname>Bloom</surname> <given-names>BR</given-names></name></person-group>. <article-title>Natural and synthetic non-peptide antigens recognized by human &#x003B3;&#x003B4; T cells</article-title>. <source>Nature</source> (<year>1995</year>) <volume>375</volume>:<fpage>155</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1038/375155a0</pub-id></citation></ref>
<ref id="B14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brandes</surname> <given-names>M</given-names></name> <name><surname>Willimann</surname> <given-names>K</given-names></name> <name><surname>Moser</surname> <given-names>B</given-names></name></person-group>. <article-title>Professional antigen-presentation function by human gammadelta T cells</article-title>. <source>Science</source> (<year>2005</year>) <volume>309</volume>:<fpage>264</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1126/science.1110267</pub-id><pub-id pub-id-type="pmid">15933162</pub-id></citation></ref>
<ref id="B15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hartwig</surname> <given-names>T</given-names></name> <name><surname>Pantelyushin</surname> <given-names>S</given-names></name> <name><surname>Croxford</surname> <given-names>AL</given-names></name> <name><surname>Kulig</surname> <given-names>P</given-names></name> <name><surname>Becher</surname> <given-names>B</given-names></name></person-group>. <article-title>Dermal IL-17-producing &#x003B3;&#x003B4; T cells establish long-lived memory in the skin</article-title>. <source>Eur J Immunol</source> (<year>2015</year>) <volume>45</volume>:<fpage>3022</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="doi">10.1002/eji.201545883</pub-id></citation></ref>
<ref id="B16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname> <given-names>AG</given-names></name> <name><surname>O&#x02019;Keeffe</surname> <given-names>KM</given-names></name> <name><surname>Lalor</surname> <given-names>SJ</given-names></name> <name><surname>Maher</surname> <given-names>BM</given-names></name> <name><surname>Mills</surname> <given-names>KHG</given-names></name> <name><surname>McLoughlin</surname> <given-names>RM</given-names></name></person-group>. <article-title><italic>Staphylococcus aureus</italic> infection of mice expands a population of memory &#x003B3;&#x003B4; T cells that are protective against subsequent infection</article-title>. <source>J Immunol</source> (<year>2014</year>) <volume>192</volume>:<fpage>3697</fpage>&#x02013;<lpage>708</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1303420</pub-id></citation></ref>
<ref id="B17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ismaili</surname> <given-names>J</given-names></name> <name><surname>Olislagers</surname> <given-names>V</given-names></name> <name><surname>Poupot</surname> <given-names>R</given-names></name> <name><surname>Fourni&#x000E9;</surname> <given-names>J-J</given-names></name> <name><surname>Goldman</surname> <given-names>M</given-names></name></person-group>. <article-title>Human gamma delta T cells induce dendritic cell maturation</article-title>. <source>Clin Immunol</source> (<year>2002</year>) <volume>103</volume>:<fpage>296</fpage>&#x02013;<lpage>302</lpage>.<pub-id pub-id-type="doi">10.1006/clim.2002.5218</pub-id><pub-id pub-id-type="pmid">12173304</pub-id></citation></ref>
<ref id="B18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rhodes</surname> <given-names>SG</given-names></name> <name><surname>Hewinson</surname> <given-names>RG</given-names></name> <name><surname>Vordermeier</surname> <given-names>HM</given-names></name></person-group>. <article-title>Antigen recognition and immunomodulation by gamma delta T cells in bovine tuberculosis</article-title>. <source>J Immunol</source> (<year>2001</year>) <volume>166</volume>:<fpage>5604</fpage>&#x02013;<lpage>10</lpage>.<pub-id pub-id-type="doi">10.4049/JIMMUNOL.166.9.5604</pub-id><pub-id pub-id-type="pmid">11313400</pub-id></citation></ref>
<ref id="B19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baldwin</surname> <given-names>CL</given-names></name> <name><surname>Sathiyaseelan</surname> <given-names>T</given-names></name> <name><surname>Rocchi</surname> <given-names>M</given-names></name> <name><surname>McKeever</surname> <given-names>D</given-names></name></person-group>. <article-title>Rapid changes occur in the percentage of circulating bovine WC1(&#x0002B;)gamma delta Th1&#x02009;cells</article-title>. <source>Res Vet Sci</source> (<year>2000</year>) <volume>69</volume>:<fpage>175</fpage>&#x02013;<lpage>80</lpage>.<pub-id pub-id-type="doi">10.1053/rvsc.2000.0410</pub-id><pub-id pub-id-type="pmid">11020371</pub-id></citation></ref>
<ref id="B20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Plattner</surname> <given-names>BL</given-names></name> <name><surname>Huffman</surname> <given-names>E</given-names></name> <name><surname>Jones</surname> <given-names>DE</given-names></name> <name><surname>Hostetter</surname> <given-names>JM</given-names></name></person-group>. <article-title>T lymphocyte responses during early enteric <italic>Mycobacterium avium</italic> subspecies paratuberculosis infection in cattle</article-title>. <source>Vet Immunol Immunopathol</source> (<year>2014</year>) <volume>157</volume>:<fpage>12</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/j.vetimm.2013.11.001</pub-id><pub-id pub-id-type="pmid">24300893</pub-id></citation></ref>
<ref id="B21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zarin</surname> <given-names>P</given-names></name> <name><surname>Chen</surname> <given-names>ELY</given-names></name> <name><surname>In</surname> <given-names>TSH</given-names></name> <name><surname>Anderson</surname> <given-names>MK</given-names></name> <name><surname>Z&#x000FA;&#x000F1;iga-Pfl&#x000FC;cker</surname> <given-names>JC</given-names></name></person-group>. <article-title>Gamma delta T-cell differentiation and effector function programming, TCR signal strength, when and how much?</article-title> <source>Cell Immunol</source> (<year>2015</year>) <volume>296</volume>:<fpage>70</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1016/j.cellimm.2015.03.007</pub-id><pub-id pub-id-type="pmid">25866401</pub-id></citation></ref>
<ref id="B22"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Plattner</surname> <given-names>BL</given-names></name> <name><surname>Doyle</surname> <given-names>RT</given-names></name> <name><surname>Hostetter</surname> <given-names>JM</given-names></name></person-group>. <article-title>Gamma&#x02013;delta T cell subsets are differentially associated with granuloma development and organization in a bovine model of mycobacterial disease</article-title>. <source>Int J Exp Pathol</source> (<year>2009</year>) <volume>90</volume>:<fpage>587</fpage>&#x02013;<lpage>97</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2613.2009.00679.x</pub-id></citation></ref>
<ref id="B23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hoek</surname> <given-names>A</given-names></name> <name><surname>Rutten</surname> <given-names>VP</given-names></name> <name><surname>Kool</surname> <given-names>J</given-names></name> <name><surname>Arkesteijn</surname> <given-names>GJ</given-names></name> <name><surname>Bouwstra</surname> <given-names>RJ</given-names></name> <name><surname>Van Rhijn</surname> <given-names>I</given-names></name> <etal/></person-group> <article-title>Subpopulations of bovine WC1(&#x0002B;) gammadelta T cells rather than CD4(&#x0002B;)CD25(high) Foxp3(&#x0002B;) T cells act as immune regulatory cells ex vivo</article-title>. <source>Vet Res</source> (<year>2009</year>) <volume>40</volume>:<fpage>6</fpage>.<pub-id pub-id-type="doi">10.1051/vetres:2008044</pub-id><pub-id pub-id-type="pmid">18928784</pub-id></citation></ref>
<ref id="B24"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guzman</surname> <given-names>E</given-names></name> <name><surname>Hope</surname> <given-names>J</given-names></name> <name><surname>Taylor</surname> <given-names>G</given-names></name> <name><surname>Smith</surname> <given-names>AL</given-names></name> <name><surname>Cubillos-Zapata</surname> <given-names>C</given-names></name> <name><surname>Charleston</surname> <given-names>B</given-names></name></person-group>. <article-title>Bovine &#x003B3;&#x003B4; T cells are a major regulatory T cell subset</article-title>. <source>J Immunol</source> (<year>2014</year>) <volume>193</volume>:<fpage>208</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1303398</pub-id><pub-id pub-id-type="pmid">24890724</pub-id></citation></ref>
<ref id="B25"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baquero</surname> <given-names>MM</given-names></name> <name><surname>Plattner</surname> <given-names>BL</given-names></name></person-group>. <article-title>Bovine WC1(&#x0002B;) &#x003B3;&#x003B4; T lymphocytes modify monocyte-derived macrophage responses during early <italic>Mycobacterium avium</italic> subspecies paratuberculosis infection</article-title>. <source>Vet Immunol Immunopathol</source> (<year>2016</year>) <volume>170</volume>:<fpage>65</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="doi">10.1016/j.vetimm.2015.12.002</pub-id></citation></ref>
<ref id="B26"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baquero</surname> <given-names>MM</given-names></name> <name><surname>Plattner</surname> <given-names>BL</given-names></name></person-group>. <article-title>Bovine peripheral blood WC1&#x0002B; and WC1neg &#x003B3;&#x003B4; T lymphocytes modulate monocyte-derived macrophage effector functions during in vitro <italic>Mycobacterium avium</italic> subspecies paratuberculosis infection</article-title>. <source>Cell Immunol</source> (<year>2017</year>) <volume>315</volume>:<fpage>34</fpage>&#x02013;<lpage>44</lpage>.<pub-id pub-id-type="doi">10.1016/j.cellimm.2017.01.009</pub-id></citation></ref>
<ref id="B27"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Subharat</surname> <given-names>S</given-names></name> <name><surname>Shu</surname> <given-names>D</given-names></name> <name><surname>Wedlock</surname> <given-names>DN</given-names></name> <name><surname>Price-Carter</surname> <given-names>M</given-names></name> <name><surname>de Lisle</surname> <given-names>GW</given-names></name> <name><surname>Luo</surname> <given-names>D</given-names></name> <etal/></person-group> <article-title>Immune responses associated with progression and control of infection in calves experimentally challenged with <italic>Mycobacterium avium</italic> subsp. paratuberculosis</article-title>. <source>Vet Immunol Immunopathol</source> (<year>2012</year>) <volume>149</volume>:<fpage>225</fpage>&#x02013;<lpage>36</lpage>.<pub-id pub-id-type="doi">10.1016/j.vetimm.2012.07.005</pub-id><pub-id pub-id-type="pmid">22871577</pub-id></citation></ref>
<ref id="B28"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lei</surname> <given-names>L</given-names></name> <name><surname>Hostetter</surname> <given-names>JM</given-names></name></person-group>. <article-title>Limited phenotypic and functional maturation of bovine monocyte-derived dendritic cells following <italic>Mycobacterium avium</italic> subspecies paratuberculosis infection in vitro</article-title>. <source>Vet Immunol Immunopathol</source> (<year>2007</year>) <volume>120</volume>:<fpage>177</fpage>&#x02013;<lpage>86</lpage>.<pub-id pub-id-type="doi">10.1016/j.vetimm.2007.06.031</pub-id><pub-id pub-id-type="pmid">17686529</pub-id></citation></ref>
<ref id="B29"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fern&#x000E1;ndez-Silva</surname> <given-names>JA</given-names></name> <name><surname>Abdulmawjood</surname> <given-names>A</given-names></name> <name><surname>Akineden</surname> <given-names>&#x000D6;</given-names></name> <name><surname>Dr&#x000E4;ger</surname> <given-names>K</given-names></name> <name><surname>Klawonn</surname> <given-names>W</given-names></name> <name><surname>B&#x000FC;lte</surname> <given-names>M</given-names></name></person-group>. <article-title>Molecular epidemiology of <italic>Mycobacterium avium</italic> subsp. paratuberculosis at a regional scale in Germany</article-title>. <source>Res Vet Sci</source> (<year>2012</year>) <volume>93</volume>:<fpage>776</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="doi">10.1016/j.rvsc.2011.12.005</pub-id><pub-id pub-id-type="pmid">22217908</pub-id></citation></ref>
<ref id="B30"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname> <given-names>RM</given-names></name> <name><surname>Gollnick</surname> <given-names>NS</given-names></name> <name><surname>Sreevatsan</surname> <given-names>S</given-names></name> <name><surname>Russell</surname> <given-names>DG</given-names></name> <name><surname>Schukken</surname> <given-names>YH</given-names></name></person-group>. <article-title>Quantification of <italic>Mycobacterium avium</italic> subsp. paratuberculosis (MAP) survival in monocyte-derived macrophages</article-title>. <source>Vet Immunol Immunopathol</source> (<year>2011</year>) <volume>139</volume>(<issue>1</issue>):<fpage>73</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.vetimm.2010.08.003</pub-id></citation></ref>
<ref id="B31"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Machugh</surname> <given-names>ND</given-names></name> <name><surname>Mburu</surname> <given-names>JK</given-names></name> <name><surname>Carol</surname> <given-names>MJ</given-names></name> <name><surname>Wyatt</surname> <given-names>CR</given-names></name> <name><surname>Orden</surname> <given-names>JA</given-names></name> <name><surname>Davis</surname> <given-names>WC</given-names></name></person-group>. <article-title>Identification of two distinct subsets of bovine gamma delta T cells with unique cell surface phenotype and tissue distribution</article-title>. <source>Immunology</source> (<year>1997</year>) <volume>92</volume>:<fpage>340</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1046/j.1365-2567.1997.00350.x</pub-id><pub-id pub-id-type="pmid">9486106</pub-id></citation></ref>
<ref id="B32"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pinchuk</surname> <given-names>L</given-names></name> <name><surname>Boyd</surname> <given-names>B</given-names></name> <name><surname>Kruger</surname> <given-names>E</given-names></name> <name><surname>Roditi</surname> <given-names>I</given-names></name> <name><surname>Furger</surname> <given-names>A</given-names></name></person-group>. <article-title>Bovine dendritic cells generated from monocytes and bone marrow progenitors regulate immunoglobulin production in peripheral blood B cells</article-title>. <source>Comp Immunol Microbiol Infect Dis</source> (<year>2003</year>) <volume>26</volume>:<fpage>233</fpage>&#x02013;<lpage>49</lpage>.<pub-id pub-id-type="doi">10.1016/S0147-9571(02)00061-9</pub-id><pub-id pub-id-type="pmid">12676124</pub-id></citation></ref>
<ref id="B33"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>De Smedt</surname> <given-names>T</given-names></name> <name><surname>Pajak</surname> <given-names>B</given-names></name> <name><surname>Muraille</surname> <given-names>E</given-names></name> <name><surname>Lespagnard</surname> <given-names>L</given-names></name> <name><surname>Heinen</surname> <given-names>E</given-names></name> <name><surname>De Baetselier</surname> <given-names>P</given-names></name> <etal/></person-group> <article-title>Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo</article-title>. <source>J Exp Med</source> (<year>1996</year>) <volume>184</volume>:<fpage>1413</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="doi">10.1084/jem.184.4.1413</pub-id></citation></ref>
<ref id="B34"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Strober</surname> <given-names>W</given-names></name></person-group>. <article-title>Trypan blue exclusion test of cell viability</article-title>. <source>Curr Protoc Immunol</source> (<year>2001</year>) Appendix 3:Appendix 3B.<pub-id pub-id-type="doi">10.1002/0471142735.ima03bs21</pub-id><pub-id pub-id-type="pmid">18432654</pub-id></citation></ref>
<ref id="B35"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoshihara</surname> <given-names>K</given-names></name> <name><surname>Nagata</surname> <given-names>R</given-names></name> <name><surname>Muneta</surname> <given-names>Y</given-names></name> <name><surname>Inumaru</surname> <given-names>S</given-names></name> <name><surname>Yokomizo</surname> <given-names>Y</given-names></name> <name><surname>Mori</surname> <given-names>Y</given-names></name></person-group>. <article-title>Generation of multinucleated giant cells in vitro from bovine monocytes and macrophages</article-title>. <source>J Vet Med Sci</source> (<year>2004</year>) <volume>66</volume>:<fpage>1065</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1292/jvms.66.1065</pub-id><pub-id pub-id-type="pmid">15472469</pub-id></citation></ref>
<ref id="B36"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ingersoll</surname> <given-names>MA</given-names></name> <name><surname>Platt</surname> <given-names>AM</given-names></name> <name><surname>Potteaux</surname> <given-names>S</given-names></name> <name><surname>Randolph</surname> <given-names>GJ</given-names></name></person-group>. <article-title>Monocyte trafficking in acute and chronic inflammation</article-title>. <source>Trends Immunol</source> (<year>2011</year>) <volume>32</volume>:<fpage>470</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1016/j.it.2011.05.001</pub-id><pub-id pub-id-type="pmid">21664185</pub-id></citation></ref>
<ref id="B37"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hope</surname> <given-names>JC</given-names></name> <name><surname>Whelan</surname> <given-names>AO</given-names></name> <name><surname>Hewinson</surname> <given-names>R</given-names></name> <name><surname>Vordermeier</surname> <given-names>M</given-names></name> <name><surname>Howard</surname> <given-names>CJ</given-names></name></person-group>. <article-title>Maturation of bovine dendritic cells by lipopeptides</article-title>. <source>Vet Immunol Immunopathol</source> (<year>2003</year>) <volume>95</volume>:<fpage>21</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="doi">10.1016/S0165-2427(03)00104-1</pub-id><pub-id pub-id-type="pmid">12969633</pub-id></citation></ref>
<ref id="B38"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alexis</surname> <given-names>NE</given-names></name> <name><surname>Lay</surname> <given-names>JC</given-names></name> <name><surname>Almond</surname> <given-names>M</given-names></name> <name><surname>Bromberg</surname> <given-names>PA</given-names></name> <name><surname>Patel</surname> <given-names>DD</given-names></name> <name><surname>Peden</surname> <given-names>DB</given-names></name></person-group>. <article-title>Acute LPS inhalation in healthy volunteers induces dendritic cell maturation in vivo</article-title>. <source>J Allergy Clin Immunol</source> (<year>2005</year>) <volume>115</volume>:<fpage>345</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="doi">10.1016/j.jaci.2004.11.040</pub-id><pub-id pub-id-type="pmid">15696093</pub-id></citation></ref>
<ref id="B39"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koets</surname> <given-names>A</given-names></name> <name><surname>Rutten</surname> <given-names>V</given-names></name> <name><surname>Hoek</surname> <given-names>A</given-names></name> <name><surname>van Mil</surname> <given-names>F</given-names></name> <name><surname>M&#x000FC;ller</surname> <given-names>K</given-names></name> <name><surname>Bakker</surname> <given-names>D</given-names></name> <etal/></person-group> <article-title>Progressive bovine paratuberculosis is associated with local loss of CD4(&#x0002B;) T cells, increased frequency of gamma delta T cells, and related changes in T-cell function</article-title>. <source>Infect Immun</source> (<year>2002</year>) <volume>70</volume>:<fpage>3856</fpage>&#x02013;<lpage>64</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.70.7.3856-3864.2002</pub-id><pub-id pub-id-type="pmid">12065529</pub-id></citation></ref>
<ref id="B40"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hussen</surname> <given-names>J</given-names></name> <name><surname>D&#x000FC;vel</surname> <given-names>A</given-names></name> <name><surname>Sandra</surname> <given-names>O</given-names></name> <name><surname>Smith</surname> <given-names>D</given-names></name> <name><surname>Sheldon</surname> <given-names>IM</given-names></name> <name><surname>Zieger</surname> <given-names>P</given-names></name> <etal/></person-group> <article-title>Phenotypic and functional heterogeneity of bovine blood monocytes</article-title>. <source>PLoS One</source> (<year>2013</year>) <volume>8</volume>:<fpage>e71502</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0071502</pub-id><pub-id pub-id-type="pmid">23967219</pub-id></citation></ref>
<ref id="B41"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Corripio-Miyar</surname> <given-names>Y</given-names></name> <name><surname>Hope</surname> <given-names>J</given-names></name> <name><surname>McInnes</surname> <given-names>CJ</given-names></name> <name><surname>Wattegedera</surname> <given-names>SR</given-names></name> <name><surname>Jensen</surname> <given-names>K</given-names></name> <name><surname>Pang</surname> <given-names>Y</given-names></name> <etal/></person-group> <article-title>Phenotypic and functional analysis of monocyte populations in cattle peripheral blood identifies a subset with high endocytic and allogeneic T-cell stimulatory capacity</article-title>. <source>Vet Res</source> (<year>2015</year>) <volume>46</volume>:<fpage>112</fpage>.<pub-id pub-id-type="doi">10.1186/s13567-015-0246-4</pub-id><pub-id pub-id-type="pmid">26407849</pub-id></citation></ref>
<ref id="B42"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cummings</surname> <given-names>HS</given-names></name> <name><surname>Ploplis</surname> <given-names>VA</given-names></name> <name><surname>Beals</surname> <given-names>JM</given-names></name> <name><surname>Castellino</surname> <given-names>FJ</given-names></name></person-group>. <article-title>Interspecies cross-reactivity of monoclonal antibodies to various epitopes of human plasminogen</article-title>. <source>Arch Biochem Biophys</source> (<year>1984</year>) <volume>230</volume>:<fpage>306</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="doi">10.1016/0003-9861(84)90112-7</pub-id><pub-id pub-id-type="pmid">6201139</pub-id></citation></ref>
<ref id="B43"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Verreck</surname> <given-names>FAW</given-names></name> <name><surname>de Boer</surname> <given-names>T</given-names></name> <name><surname>Langenberg</surname> <given-names>DML</given-names></name> <name><surname>van der Zanden</surname> <given-names>L</given-names></name> <name><surname>Ottenhoff</surname> <given-names>THM</given-names></name></person-group>. <article-title>Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-gamma- and CD40L-mediated costimulation</article-title>. <source>J Leukoc Biol</source> (<year>2006</year>) <volume>79</volume>:<fpage>285</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="doi">10.1189/jlb.0105015</pub-id><pub-id pub-id-type="pmid">16330536</pub-id></citation></ref>
<ref id="B44"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Park</surname> <given-names>KT</given-names></name> <name><surname>Burnett</surname> <given-names>S</given-names></name> <name><surname>Davis</surname> <given-names>WC</given-names></name></person-group>. <article-title>Development and characterization of a monoclonal antibody specific for bovine CD209</article-title>. <source>Vet Immunol Immunopathol</source> (<year>2015</year>) <volume>163</volume>(<issue>3</issue>):<fpage>216</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1016/j.vetimm.2014.12.008</pub-id></citation></ref>
<ref id="B45"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kitani</surname> <given-names>H</given-names></name> <name><surname>Yoshioka</surname> <given-names>M</given-names></name> <name><surname>Takenouchi</surname> <given-names>T</given-names></name> <name><surname>Sato</surname> <given-names>M</given-names></name> <name><surname>Yamanaka</surname> <given-names>N</given-names></name></person-group>. <article-title>Isolation and characterization of macrophages from a mixed primary culture of bovine liver cells</article-title>. <source>Vet Immunol Immunopathol</source> (<year>2011</year>) <volume>140</volume>(<issue>3</issue>):<fpage>341</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1016/j.vetimm.2011.01.011</pub-id></citation></ref>
<ref id="B46"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hussen</surname> <given-names>J</given-names></name> <name><surname>Koy</surname> <given-names>M</given-names></name> <name><surname>Petzl</surname> <given-names>W</given-names></name> <name><surname>Schuberth</surname> <given-names>H-J</given-names></name></person-group>. <article-title>Neutrophil degranulation differentially modulates phenotype and function of bovine monocyte subsets</article-title>. <source>Innate Immun</source> (<year>2016</year>) <volume>22</volume>:<fpage>124</fpage>&#x02013;<lpage>37</lpage>.<pub-id pub-id-type="doi">10.1177/1753425915620911</pub-id><pub-id pub-id-type="pmid">26644394</pub-id></citation></ref>
<ref id="B47"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mansouri-Attia</surname> <given-names>N</given-names></name> <name><surname>Oliveira</surname> <given-names>LJ</given-names></name> <name><surname>Forde</surname> <given-names>N</given-names></name> <name><surname>Fahey</surname> <given-names>AG</given-names></name> <name><surname>Browne</surname> <given-names>JA</given-names></name> <name><surname>Roche</surname> <given-names>JF</given-names></name> <etal/></person-group> <article-title>Pivotal role for monocytes/macrophages and dendritic cells in maternal immune response to the developing embryo in cattle</article-title>. <source>Biol Reprod</source> (<year>2012</year>) <volume>87</volume>:<fpage>123</fpage>.<pub-id pub-id-type="doi">10.1095/biolreprod.112.101121</pub-id><pub-id pub-id-type="pmid">23034158</pub-id></citation></ref>
<ref id="B48"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Norimatsu</surname> <given-names>M</given-names></name> <name><surname>Harris</surname> <given-names>J</given-names></name> <name><surname>Chance</surname> <given-names>V</given-names></name> <name><surname>Dougan</surname> <given-names>G</given-names></name> <name><surname>Howard</surname> <given-names>CJ</given-names></name> <name><surname>Villarreal-Ramos</surname> <given-names>B</given-names></name></person-group>. <article-title>Differential response of bovine monocyte-derived macrophages and dendritic cells to infection with <italic>Salmonella typhimurium</italic> in a low-dose model in vitro</article-title>. <source>Immunology</source> (<year>2003</year>) <volume>108</volume>:<fpage>55</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="doi">10.1046/j.1365-2567.2003.01557.x</pub-id><pub-id pub-id-type="pmid">12519303</pub-id></citation></ref>
<ref id="B49"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Umemura</surname> <given-names>M</given-names></name> <name><surname>Yahagi</surname> <given-names>A</given-names></name> <name><surname>Hamada</surname> <given-names>S</given-names></name> <name><surname>Begum</surname> <given-names>MD</given-names></name> <name><surname>Watanabe</surname> <given-names>H</given-names></name> <name><surname>Kawakami</surname> <given-names>K</given-names></name> <etal/></person-group> <article-title>IL-17-mediated regulation of innate and acquired immune response against pulmonary <italic>Mycobacterium bovis</italic> bacille Calmette-Guerin infection</article-title>. <source>J Immunol</source> (<year>2007</year>) <volume>178</volume>:<fpage>3786</fpage>&#x02013;<lpage>96</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.178.6.3786</pub-id><pub-id pub-id-type="pmid">17339477</pub-id></citation></ref>
<ref id="B50"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Casals</surname> <given-names>C</given-names></name> <name><surname>Barrachina</surname> <given-names>M</given-names></name> <name><surname>Serra</surname> <given-names>M</given-names></name> <name><surname>Lloberas</surname> <given-names>J</given-names></name> <name><surname>Celada</surname> <given-names>A</given-names></name></person-group>. <article-title>Lipopolysaccharide up-regulates MHC class II expression on dendritic cells through an AP-1 enhancer without affecting the levels of CIITA</article-title>. <source>J Immunol</source> (<year>2007</year>) <volume>178</volume>:<fpage>6307</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="doi">10.4049/JIMMUNOL.178.10.6307</pub-id><pub-id pub-id-type="pmid">17475859</pub-id></citation></ref>
<ref id="B51"><label>51</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname> <given-names>DJ</given-names></name> <name><surname>Evanson</surname> <given-names>OA</given-names></name> <name><surname>Mcclenahan</surname> <given-names>DJ</given-names></name> <name><surname>Abrahamsen</surname> <given-names>MS</given-names></name> <name><surname>Walcheck</surname> <given-names>BK</given-names></name></person-group>. <article-title>Regulation of expression of major histocompatibility antigens by bovine macrophages infected with <italic>Mycobacterium avium</italic> subsp. paratuberculosis or <italic>Mycobacterium avium</italic> subsp. avium</article-title>. <source>Infect Immun</source> (<year>2001</year>) <volume>69</volume>:<fpage>1002</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.69.2.1002-1008.2001</pub-id></citation></ref>
<ref id="B52"><label>52</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Devilder</surname> <given-names>M-C</given-names></name> <name><surname>Maillet</surname> <given-names>S</given-names></name> <name><surname>Bouyge-Moreau</surname> <given-names>I</given-names></name> <name><surname>Donnadieu</surname> <given-names>E</given-names></name> <name><surname>Bonneville</surname> <given-names>M</given-names></name> <name><surname>Scotet</surname> <given-names>E</given-names></name></person-group>. <article-title>Potentiation of antigen-stimulated V 9V 2 T cell cytokine production by immature dendritic cells (DC) and reciprocal effect on DC maturation</article-title>. <source>J Immunol</source> (<year>2006</year>) <volume>176</volume>:<fpage>1386</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.176.3.1386</pub-id></citation></ref>
</ref-list>
</back>
</article>